why choose us

First received: December 17, 2024

Clinical Trial: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Essential Hypertension

Study Type: INTERVENTIONAL


Official Title: An Open-label, Randomized, Fed, Single-dose, 2-sequence, 4-period, Crossover Phase I Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR101

Brief Summary: The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015 and co-administration of BR1015-3 and BR1015-2 in healthy volunteers under fed conditions

Read more